Syringes and Needles Market Size - Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034

Syringes and Needles Market Size

The global syringes and needles market generated substantial revenues in 2024 and is expected to grow at a substantial CAGR during 2025-2034 driven by the increasing need for injectable medicines, and the growing number of chronic illnesses like diabetes and cancer. As per the International Diabetes Federation, approximately 589 million adults (ages 20-79) were living with diabetes in 2024, and the count is expected to reach 853 million by 2050. The steep rise in disposable syringes and needles is due to all the safety features, easy usability, and reduction in risk for infections. The new technological developments, such as auto-disable syringes and needle-free injections are starting to set the stage for the future of this market and persuade innovation to continue meeting the ever-changing landscape of healthcare.

Another major market growth has been the rise in vaccination programs worldwide, owing to the COVID-19 pandemic and other viral infections. Government and global health groups have greatly improved the delivery of vaccinations (for COVID-19 infection and other infections such as influenza, measles, and hepatitis). Demand for syringes and needles as part of vaccination and distribution has been at an unprecedented high. Furthermore, the introduction of new vaccines, including those for new diseases, will further entrench demand for syringes and needles.
 

Immunization initiatives are being expanded in developing areas, where healthcare infrastructure is being developed and investments have the potential to ensure that public health campaigns are more broad-based and accessible. While there are many opportunities fueling growth, there are a number of restraint in the syringes and needles industry. The development costs of advanced technology solutions is a major barrier. Advanced syringes, such as auto-disable syringes, and advanced technologies, such as needle-free injection systems, tend to have much higher production costs than standard syringes and needles. Thus, healthcare providers opt for lower-cost options, particularly in developing markets or where cost containment has major implications.
 

Syringes and Needles Market Trends

There are several major trends impacting the syringes and needles industry. Firstly, as syringe technology advances, there are going to be increasing choices for both the clinician and the patient, and that includes auto-disable syringes and prefilled syringes. Auto-disable syringes are made specifically to be used once and not re-used, as with others it is important to prevent re-use to stem the risks of infection. There are a few needle-free injection systems coming into the market, which are alternatives to traditional syringes and needles that are particularly helpful to those with needle phobia.
 

Another growing trend is sustainability. As sustainability becomes more of a focus in medicine, manufacturers are beginning to investigate biodegradable and other reusable options to lessen the impact of disposable syringes in our landfills. Needle-free syringes are important as there is a growing demand for more efficient, safe, user-friendly products, requiring less space in the crowded market.
 

Syringes and Needles Market Analysis

The disposable syringes and needles segment held a substantial share in 2024. These syringes and needles are attractive, single-use, and significantly reduce the risk of contamination. Disposable syringes are now standard in, clinical and homecare applications for the use of vaccine administration, insulin injections, and other injectable therapies. This segment is supported by regulatory requirements in many parts of the world to use disposable and safety-engineered products to promote patient safety and reduce the risk of healthcare-associated infections (HAIs). As the focus on patient safety becomes increasingly important, hospitals and outpatient clinics will demand more disposable syringes and needles. Prefilled syringes, help to promote accurate dosing of drugs and facilitate efficient patient care are helping to drive the growth of this segment.
 

The hospital's segment in the syringes and needles market held robust growth in 2024. As the largest single consumers of syringes and needles, hospitals account for a large portion of the revenue generated from sales of these products. The increasing number of surgeries, treatments, and vaccinations conducted each day, and the need for continuing or repeating treatments or injections, make hospitals the biggest purchasers of syringes and needles.
 

The increasing number of chronic illnesses that require injectable therapies, such as diabetes, cancer, cardiovascular disease, and related disorders, will further increase the demand for syringes and needles. Hospitals are also commencing to purchase increasingly safety-engineered syringes to reduce the risk of needlestick injuries and enhance components of infection control. Hospitals are moving towards single-use disposable syringes with also a growing focus on stricter regulations, standards, and patient safety protocol. The above conditions, coupled with the need for injectable medications in a hospital setting, will continue to fuel demand for syringes and needles in the foreseeable future.
 

North America market is expected to grow at a notable CAGR during 2025- 2034. Healthcare infrastructure and expenditure are strong in North America, and the aging population that requires injectables for a variety of chronic conditions also drives syringe and needle sales. In particular, the US is an important area for syringes and needles, as the country's outpatient settings have a very high demand for syringes, as does inpatient. The continued rise of chronic conditions, such as diabetes, hypertension, and obesity contributes to the increased usage of syringes and needles. The US region's emphasis on regulation of medical devices provides assurance that syringe manufacturers must also utilize the safest and most effective syringes in the market. The growing interest in innovations such as needle-free injection systems and prefilled syringes is another benefit to syringes and needles growth in North America.
 

Syringes and Needles Market Share

Major companies involved in the syringes and needles industry include:

• Terumo Corporation
• Smiths Medical
• Cardinal Health Inc.
• Fisher Scientific
• B. Braun Medical Inc.
• Albert David Ltd
• C.R. Bard (Becton Dickinson)
• Hamilton
• Merck
• Covidien Plc
   

Companies within the syringes and needles industry are pursuing many different approaches to gain market share. Many are focused on research & development (R&D) aimed at developing innovative products (safety-engineered syringes and needle-free injection technologies) that lead to improved patient safety and convenience. Companies are also entering into strategic partnerships and other collaborations with healthcare professionals, government-based organizations, and research institutions to gain traction in emerging markets that are experiencing strong demand for medical devices.
 

Leading manufacturers are investing vast sums of money in advanced manufacturing technologies to promote efficiencies in the manufacturing process, decrease costs, and satisfy the growing global demand for syringes and needles. Improving supply chain management is a large part of the companies developing methods to reliably provide products to hospitals, clinics, and homecare patients in a timely manner. Lastly, perhaps most importantly, regulatory compliance with international standards and certifying procedures are crucial strategies to secure timely purchase orders from hospitals and healthcare providers, where trust in the safety and quality of the product is paramount.
 

Syringes and Needles Industry News

• In September 2023, PDO MAX, Inc., a woman-owned medical device company based in the United States, introduced its third innovation. The company unveiled its latest product: the Glowpin serum infusion system, which combined a multi-needle stimulator with an airless pump.
   
• In March 2024, Hindustan Syringes and Medical Devices (HMD) launched the Dispojekt single-use syringes with safety needles, further strengthening India’s position as a global powerhouse in medical devices. With the introduction of the Dispojekt safety syringes, HMD aimed to reduce the prevalence of accidental needle-stick injuries among healthcare workers, thereby cutting down on infection control costs.